Live
- Maha Oppn to boycott customary CM tea meet, cites rising farmers' distress, atrocities against Dalits
- Mikheil Kavelashvili is new Georgian President
- He makes things look easy: Smith on 241-run partnership with Head
- Decline in TB cases & deaths in India ‘remarkable’, shows ‘political commitment’, says former WHO Director
- PKL 11: Delhi dedicates win over Haryana to ‘junior express’
- Cyclone kills 14 in French territory Mayotte
- 3rd Test: Head, Smith centuries flatten India on Day 2
- AAP Announces Final Candidate List For 2025 Delhi Assembly Elections, Kejriwal To Contest From New Delhi
- Bangladesh unrest has delayed execution of some vital projects: Tripura CM
- PIL in SC seeks direction to designate BMC as sole planning, sanctioning authority for Mumbai
Covishield dose gap to be reduced
Covishield dose gap to be reduced
India's top body on immunisation NTAGI has recommended administering the second dose of Covid-19 vaccine Covishield between eight and 16 weeks after the first dose, official sources said.
New Delhi: India's top body on immunisation NTAGI has recommended administering the second dose of Covid-19 vaccine Covishield between eight and 16 weeks after the first dose, official sources said. Presently, the second dose of Covishield is given between 12-16 weeks after the first dose under the National Covid-19 Vaccination Strategy.
The National Technical Advisory Group on Immunisation (NTAGI) has not yet suggested any change in the schedule of Bharat Biotech's Covaxin, whose second dose is administered 28 days after the first dose. The recommendation for Covishield is yet to be implemented in the national COVID-19 vaccination programme. "The latest recommendation of NTAGI is based on recent global scientific evidence derived from programmatic data," said an official source.
"According to it, when the second dose of Covishield is given eight weeks onwards, the antibody response generated is almost similar when administered at an interval of 12 to 16 weeks," the source explained. The decision will lead to accelerated administration of the second dose of Covishield to the remaining six to seven crore individuals amid rising cases in several countries, the source said.
